Gynecologic Cancer clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
open to eligible females ages 18 years and up
- To compare acute toxicity and chemotherapy delivery for atlas-based IG-IMRT vs. PET/CT-based IG-IMRT vs. conventional RT, and assess the impact of treatment on changes in hematopoietic compensatory response. 2. To develop and validate machine learning and radiomics techniques for dose accumulation, automated treatment planning, and prediction of treatment response.
Our lead scientists for Gynecologic Cancer research studies include Loren K Mell, MD.